The FDA is reviewing the peptide for ulcerative colitis, a chronic inflammatory bowel disease, but its often marketed for muscle and tissue recovery
concurrently, BNIP3 recruits Parkin to mitochondria to initiate autophagic flux, whereas NIXas a ubiquitination substrate of Parkinundergoes conformational remodeling post-modification to specifically engage adaptor protein NBR1, ultimately enabling targeted autophagic degradation of compromised mitochondria (Wang et al., 2023)
A.PanchenkoL
The Wolverine Stack pairs both peptides in a single research protocol so local vessel formation and systemic cell recruitment can be observed together a preclinical hypothesis, not a proven human treatment
V., & Kolik, L
Janoshik, Freedom Diagnostics, BioRegen, Bioviridian, and BioChex all provide such portals